HEADER STRUCTURAL PROTEIN 29-MAR-06 2DI9 TITLE SOLUTION STRUCTURE OF THE 9TH FILAMIN DOMAIN FROM HUMAN FILAMIN-B COMPND MOL_ID: 1; COMPND 2 MOLECULE: FILAMIN-B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FILAMIN DOMAIN; COMPND 5 SYNONYM: FLN-B, BETA-FILAMIN, ACTIN-BINDING-LIKE PROTEIN, THYROID COMPND 6 AUTOANTIGEN, TRUNCATED ACTIN-BINDING PROTEIN, TRUNCATED ABP, ABP-280 COMPND 7 HOMOLOG, ABP-278, FILAMIN 3, FILAMIN HOMOLOG 1, FH1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FLNB; SOURCE 6 EXPRESSION_SYSTEM: CELL FREE SYNTHESIS; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: P051205-13; SOURCE 9 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS BETA-SANDWICH, IMMUNOGLOBULIN-LIKE FOLD, FILAMIN DOMAIN, STRUCTURAL KEYWDS 2 GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND KEYWDS 3 FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 4 INITIATIVE, RSGI, STRUCTURAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.TOMIZAWA,S.KOSHIBA,S.WATANABE,T.HARADA,T.KIGAWA,S.YOKOYAMA,RIKEN AUTHOR 2 STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 09-MAR-22 2DI9 1 REMARK SEQADV REVDAT 2 24-FEB-09 2DI9 1 VERSN REVDAT 1 29-SEP-06 2DI9 0 JRNL AUTH T.TOMIZAWA,S.KOSHIBA,S.WATANABE,T.HARADA,T.KIGAWA,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE 9TH FILAMIN DOMAIN FROM HUMAN JRNL TITL 2 FILAMIN-B JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DI9 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000025445. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.11MM FILAMIN DOMAIN U-15N,13C; REMARK 210 20MM D-TRIS-HCL(PH 7.0); 100MM REMARK 210 NACL; 1MM D-DTT; 0.02% NAN3; 10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20030801, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9742, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 RESTRAINTED MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION, STRUCTURES WITH REMARK 210 THE LOWEST ENERGY, STRUCTURES REMARK 210 WITH THE LEAST RESTRAINT REMARK 210 VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 17 1.02 -69.78 REMARK 500 1 GLU A 24 28.67 37.30 REMARK 500 1 SER A 26 73.06 -112.09 REMARK 500 1 ALA A 59 -55.00 -123.05 REMARK 500 1 PRO A 110 82.67 -69.72 REMARK 500 2 TYR A 11 137.23 -171.90 REMARK 500 2 ASP A 12 143.40 -172.22 REMARK 500 2 TYR A 21 44.04 -85.35 REMARK 500 2 GLU A 24 47.97 -101.11 REMARK 500 2 PRO A 110 83.05 -69.80 REMARK 500 2 SER A 125 113.58 -35.04 REMARK 500 2 SER A 129 36.95 70.35 REMARK 500 3 ASP A 12 114.40 -163.07 REMARK 500 3 VAL A 23 38.66 -89.67 REMARK 500 3 SER A 26 50.58 -113.52 REMARK 500 3 PRO A 110 85.19 -69.78 REMARK 500 4 ASP A 12 -49.47 -130.10 REMARK 500 4 PRO A 20 2.82 -69.78 REMARK 500 4 TYR A 21 40.21 -82.05 REMARK 500 4 GLU A 24 40.64 -109.49 REMARK 500 4 ALA A 25 31.78 -90.73 REMARK 500 4 SER A 26 124.62 -171.86 REMARK 500 4 VAL A 34 105.74 -57.22 REMARK 500 4 PRO A 110 84.34 -69.74 REMARK 500 4 PRO A 124 -173.20 -69.73 REMARK 500 4 SER A 129 170.52 -45.75 REMARK 500 5 SER A 5 44.60 -92.54 REMARK 500 5 ASP A 12 118.96 -169.26 REMARK 500 5 PRO A 17 -179.98 -69.75 REMARK 500 5 PRO A 20 0.62 -69.79 REMARK 500 5 TYR A 21 38.72 -83.55 REMARK 500 5 GLU A 24 36.10 -87.74 REMARK 500 5 GLU A 106 30.32 72.17 REMARK 500 5 PRO A 110 83.99 -69.79 REMARK 500 5 PHE A 122 160.88 -48.14 REMARK 500 5 PRO A 124 85.16 -69.77 REMARK 500 6 PRO A 20 2.78 -69.70 REMARK 500 6 TYR A 21 32.63 -95.06 REMARK 500 6 GLU A 24 40.64 -87.97 REMARK 500 6 SER A 26 109.68 -174.96 REMARK 500 6 GLU A 73 108.24 -53.18 REMARK 500 6 SER A 87 75.13 -108.20 REMARK 500 6 PRO A 110 82.04 -69.87 REMARK 500 7 THR A 10 124.80 -35.94 REMARK 500 7 ASP A 12 106.83 -165.62 REMARK 500 7 TYR A 21 34.34 36.54 REMARK 500 7 SER A 26 73.93 -106.70 REMARK 500 7 GLU A 69 44.85 -82.91 REMARK 500 7 PRO A 110 83.89 -69.76 REMARK 500 7 PRO A 121 -179.24 -69.78 REMARK 500 REMARK 500 THIS ENTRY HAS 146 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSK003002600.4 RELATED DB: TARGETDB DBREF 2DI9 A 8 125 UNP O75369 FLNB_HUMAN 1017 1134 SEQADV 2DI9 GLY A 1 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 SER A 2 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 SER A 3 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 GLY A 4 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 SER A 5 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 SER A 6 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 GLY A 7 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 SER A 126 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 GLY A 127 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 PRO A 128 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 SER A 129 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 SER A 130 UNP O75369 CLONING ARTIFACT SEQADV 2DI9 GLY A 131 UNP O75369 CLONING ARTIFACT SEQRES 1 A 131 GLY SER SER GLY SER SER GLY ASP VAL THR TYR ASP GLY SEQRES 2 A 131 HIS PRO VAL PRO GLY SER PRO TYR THR VAL GLU ALA SER SEQRES 3 A 131 LEU PRO PRO ASP PRO SER LYS VAL LYS ALA HIS GLY PRO SEQRES 4 A 131 GLY LEU GLU GLY GLY LEU VAL GLY LYS PRO ALA GLU PHE SEQRES 5 A 131 THR ILE ASP THR LYS GLY ALA GLY THR GLY GLY LEU GLY SEQRES 6 A 131 LEU THR VAL GLU GLY PRO CYS GLU ALA LYS ILE GLU CYS SEQRES 7 A 131 SER ASP ASN GLY ASP GLY THR CYS SER VAL SER TYR LEU SEQRES 8 A 131 PRO THR LYS PRO GLY GLU TYR PHE VAL ASN ILE LEU PHE SEQRES 9 A 131 GLU GLU VAL HIS ILE PRO GLY SER PRO PHE LYS ALA ASP SEQRES 10 A 131 ILE GLU MET PRO PHE ASP PRO SER SER GLY PRO SER SER SEQRES 11 A 131 GLY HELIX 1 1 ASP A 30 VAL A 34 5 5 HELIX 2 2 GLY A 38 GLU A 42 1 5 SHEET 1 A 4 LYS A 35 HIS A 37 0 SHEET 2 A 4 ALA A 50 ASP A 55 -1 O ASP A 55 N LYS A 35 SHEET 3 A 4 THR A 85 LEU A 91 -1 O TYR A 90 N ALA A 50 SHEET 4 A 4 LYS A 75 ASP A 80 -1 N GLU A 77 O SER A 89 SHEET 1 B 4 GLY A 43 LEU A 45 0 SHEET 2 B 4 PHE A 114 GLU A 119 1 O GLU A 119 N GLY A 44 SHEET 3 B 4 GLU A 97 PHE A 104 -1 N TYR A 98 O ALA A 116 SHEET 4 B 4 LEU A 64 VAL A 68 -1 N GLY A 65 O LEU A 103 CISPEP 1 SER A 112 PRO A 113 1 0.01 CISPEP 2 SER A 112 PRO A 113 2 -0.03 CISPEP 3 SER A 112 PRO A 113 3 0.05 CISPEP 4 SER A 112 PRO A 113 4 0.01 CISPEP 5 SER A 112 PRO A 113 5 0.02 CISPEP 6 SER A 112 PRO A 113 6 -0.03 CISPEP 7 SER A 112 PRO A 113 7 -0.03 CISPEP 8 SER A 112 PRO A 113 8 0.00 CISPEP 9 SER A 112 PRO A 113 9 -0.09 CISPEP 10 SER A 112 PRO A 113 10 0.02 CISPEP 11 SER A 112 PRO A 113 11 -0.05 CISPEP 12 SER A 112 PRO A 113 12 -0.02 CISPEP 13 SER A 112 PRO A 113 13 -0.03 CISPEP 14 SER A 112 PRO A 113 14 0.04 CISPEP 15 SER A 112 PRO A 113 15 -0.03 CISPEP 16 SER A 112 PRO A 113 16 -0.10 CISPEP 17 SER A 112 PRO A 113 17 -0.06 CISPEP 18 SER A 112 PRO A 113 18 -0.06 CISPEP 19 SER A 112 PRO A 113 19 -0.05 CISPEP 20 SER A 112 PRO A 113 20 0.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1